Robert W. Greene
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Robert W. Greene has a total of 197 co-authors. Here are the top co-authors by number of shared publications:
- Robert W. McCarley
Harvard Medical School
13 shared publications H.L. Haas
7 shared publications- Ashwinikumar Kulkarni
Department of Neuroscience, UT Southwestern Medical Center, Dallas, TX 75390, USA
5 shared publications - Donald Gordon Rainnie
Division of Behavioral Neuroscience and Psychiatric Disorders, Yerkes National Primate Research Center, Atlanta, GA, USA
5 shared publications - Genevieve Konopka
Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, USA
5 shared publications - Alex Sonneborn
Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR
4 shared publications
Latest Publications
- Open Access
Isoflurane anesthesia CNS recovery state: ultra-slow oscillations and cellular-stress-responsive gene expression
General anesthesia and NREM sleep share slow-wave EEG features, yet whether anesthesia substitutes for physiological sleep remains unclear. We compared recovery from 4h of isoflurane anesthesia (IA) with time-matched sleep and sleep deprivation (SD) in male C57BL/6J mice using continuous EEG/EMG recordings and frontal cortex RNA sequencing. IA recovery produced transient, rebound arousal, reduced early NREM and REM sleep, and, fragmented subsequent NREM bouts, and persistant, ultra-slow EEG-oscillations that normalized within two weeks. Whereas, SD induced consolidated rebound sleep and slow wave activity. Transcriptomic profiling at ZT6 showed that IA and SD induced largely distinct cortical gene-expression programs. IA preferentially enriched integrated stress response and unfolded protein response genes, whereas SD showed a comparatively orthogonal, growth-permissive, mTOR-associated profile. Although IA-induced gene-expression suggests cellular stress, corticosterone measurements argued against systemic stress as the primary driver. These findings indicate that isoflurane recovery is neurophysiologically and molecularly distinct from restorative sleep.
Open AccessIsoflurane anesthesia CNS recovery state: ultra-slow oscillations and cellular-stress-responsive gene expression
General anesthesia and NREM sleep share slow-wave EEG features, yet whether anesthesia substitutes for physiological sleep remains unclear. We compared recovery from 4h of isoflurane anesthesia (IA) with time-matched sleep and sleep deprivation (SD) in male C57BL/6J mice using continuous EEG/EMG recordings and frontal cortex RNA sequencing. IA recovery produced transient, rebound arousal, reduced early NREM and REM sleep, and, fragmented subsequent NREM bouts, and persistant, ultra-slow EEG-oscillations that normalized within two weeks. Whereas, SD induced consolidated rebound sleep and slow wave activity. Transcriptomic profiling at ZT6 showed that IA and SD induced largely distinct cortical gene-expression programs. IA preferentially enriched integrated stress response and unfolded protein response genes, whereas SD showed a comparatively orthogonal, growth-permissive, mTOR-associated profile. Although IA-induced gene-expression suggests cellular stress, corticosterone measurements argued against systemic stress as the primary driver. These findings indicate that isoflurane recovery is neurophysiologically and molecularly distinct from restorative sleep.
- Open Access
- 25 February 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (5)
TCF4’s role in sleep/wake state and sleep function
- 25 February 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (5)
Open AccessTCF4’s role in sleep/wake state and sleep function
- Open Access
- 14 February 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Sleep need driven oscillation of glutamate synaptic phenotype
Sleep loss increases AMPA-synaptic strength and number in the neocortex. However, this is only part of the synaptic sleep loss response. We report an increased AMPA/NMDA EPSC ratio in frontal-cortical pyramidal neurons of layers 2–3. Silent synapses are absent, decreasing the plastic potential to convert silent NMDA to active AMPA synapses. These sleep loss changes are recovered by sleep. Sleep genes are enriched for synaptic shaping cellular components controlling glutamate synapse phenotype, overlap with autism risk genes, and are primarily observed in excitatory pyramidal neurons projecting intra-telencephalically. These genes are enriched with genes controlled by the transcription factor, MEF2c, and its repressor, HDAC4. Sleep genes can thus provide a framework within which motor learning and training occur mediated by the sleep-dependent oscillation of glutamate-synaptic phenotypes.
- 14 February 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Open AccessSleep need driven oscillation of glutamate synaptic phenotype
Sleep loss increases AMPA-synaptic strength and number in the neocortex. However, this is only part of the synaptic sleep loss response. We report an increased AMPA/NMDA EPSC ratio in frontal-cortical pyramidal neurons of layers 2–3. Silent synapses are absent, decreasing the plastic potential to convert silent NMDA to active AMPA synapses. These sleep loss changes are recovered by sleep. Sleep genes are enriched for synaptic shaping cellular components controlling glutamate synapse phenotype, overlap with autism risk genes, and are primarily observed in excitatory pyramidal neurons projecting intra-telencephalically. These genes are enriched with genes controlled by the transcription factor, MEF2c, and its repressor, HDAC4. Sleep genes can thus provide a framework within which motor learning and training occur mediated by the sleep-dependent oscillation of glutamate-synaptic phenotypes.
- Open Access
- 27 January 2025
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Sleep need driven oscillation of glutamate synaptic phenotype
Sleep loss increases AMPA-synaptic strength and number in the neocortex. However, this is only part of the synaptic sleep loss response. We report increased AMPA/NMDA EPSC ratio in frontal-cortical pyramidal neurons of layers 2-3. Silent synapses are absent, decreasing the plastic potential to convert silent NMDA to active AMPA synapses. These sleep loss changes are recovered by sleep. Sleep genes are enriched for synaptic shaping cellular components controlling glutamate synapse phenotype, overlap with autism risk genes and are primarily observed in excitatory pyramidal neurons projecting intra-telencephalically. These genes are enriched with genes controlled by the transcription factor, MEF2c and its repressor, HDAC4. Sleep genes can thus provide a framework within which motor learning and training occurs mediated by sleep-dependent oscillation of glutamate-synaptic phenotypes.
- 27 January 2025
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Open AccessSleep need driven oscillation of glutamate synaptic phenotype
Sleep loss increases AMPA-synaptic strength and number in the neocortex. However, this is only part of the synaptic sleep loss response. We report increased AMPA/NMDA EPSC ratio in frontal-cortical pyramidal neurons of layers 2-3. Silent synapses are absent, decreasing the plastic potential to convert silent NMDA to active AMPA synapses. These sleep loss changes are recovered by sleep. Sleep genes are enriched for synaptic shaping cellular components controlling glutamate synapse phenotype, overlap with autism risk genes and are primarily observed in excitatory pyramidal neurons projecting intra-telencephalically. These genes are enriched with genes controlled by the transcription factor, MEF2c and its repressor, HDAC4. Sleep genes can thus provide a framework within which motor learning and training occurs mediated by sleep-dependent oscillation of glutamate-synaptic phenotypes.
- Open Access
Sleep need driven oscillation of glutamate synaptic phenotype
Sleep loss increases AMPA-synaptic strength and number in the neocortex. However, this is only part of the synaptic sleep loss response. We report increased AMPA/NMDA EPSC ratio in frontal-cortical pyramidal neurons of layers 2-3. Silent synapses are absent, decreasing the plastic potential to convert silent NMDA to active AMPA synapses. These sleep loss changes are recovered by sleep. Sleep genes are enriched for synaptic shaping cellular components controlling glutamate synapse phenotype, overlap with autism risk genes and are primarily observed in excitatory pyramidal neurons projecting intra-telencephalically. These genes are enriched with genes controlled by the transcription factor, MEF2c and its repressor, HDAC4. Sleep genes can thus provide a framework within which motor learning and training occurs mediated by sleep-dependent oscillation of glutamate-synaptic phenotypes.
Open AccessSleep need driven oscillation of glutamate synaptic phenotype
Sleep loss increases AMPA-synaptic strength and number in the neocortex. However, this is only part of the synaptic sleep loss response. We report increased AMPA/NMDA EPSC ratio in frontal-cortical pyramidal neurons of layers 2-3. Silent synapses are absent, decreasing the plastic potential to convert silent NMDA to active AMPA synapses. These sleep loss changes are recovered by sleep. Sleep genes are enriched for synaptic shaping cellular components controlling glutamate synapse phenotype, overlap with autism risk genes and are primarily observed in excitatory pyramidal neurons projecting intra-telencephalically. These genes are enriched with genes controlled by the transcription factor, MEF2c and its repressor, HDAC4. Sleep genes can thus provide a framework within which motor learning and training occurs mediated by sleep-dependent oscillation of glutamate-synaptic phenotypes.
- 1 January 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 740, 135450
Norepinephrine transporter antagonism prevents dopamine-dependent synaptic plasticity in the mouse dorsal hippocampus
- 1 January 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 740, 135450
Norepinephrine transporter antagonism prevents dopamine-dependent synaptic plasticity in the mouse dorsal hippocampus
- Open Access
- 2 November 2020
- Published by Society for Neuroscience in eneuro
- Vol. 7 (6)
Sleep Deprivation Enhances Cocaine Conditioned Place Preference in an Orexin Receptor-Modulated Manner
Drug addiction and withdrawal are characterized by sleep disruption, but the effects of sleep disruption on these states are not well characterized. Sleep deprivation (SD) immediately before the cocaine conditioning trials enhanced cocaine conditioned place preference (CPP) in a dose-dependent manner (3, 8 mg/kg but not 15 mg/kg) in mice. SD immediately before the postconditioning test also enhanced cocaine CPP preference in a dose-dependent manner (8 mg/kg, but not 3, 15 mg/kg). Exposure to orexin-receptor antagonism (1 mg/kg SB 334867, an orexin 1 receptor antagonist; OX1R) just before cocaine-conditioning trials or the postconditioning test attenuated SD-enhanced preference. This suggests a potential therapeutic role for the manipulation of the orexin system to mitigate drug seeking, especially in the context of sleep loss before drug exposure.
- 2 November 2020
- Published by Society for Neuroscience in eneuro
- Vol. 7 (6)
Open AccessSleep Deprivation Enhances Cocaine Conditioned Place Preference in an Orexin Receptor-Modulated Manner
Drug addiction and withdrawal are characterized by sleep disruption, but the effects of sleep disruption on these states are not well characterized. Sleep deprivation (SD) immediately before the cocaine conditioning trials enhanced cocaine conditioned place preference (CPP) in a dose-dependent manner (3, 8 mg/kg but not 15 mg/kg) in mice. SD immediately before the postconditioning test also enhanced cocaine CPP preference in a dose-dependent manner (8 mg/kg, but not 3, 15 mg/kg). Exposure to orexin-receptor antagonism (1 mg/kg SB 334867, an orexin 1 receptor antagonist; OX1R) just before cocaine-conditioning trials or the postconditioning test attenuated SD-enhanced preference. This suggests a potential therapeutic role for the manipulation of the orexin system to mitigate drug seeking, especially in the context of sleep loss before drug exposure.
- Open Access
- 23 October 2020
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 40 (48) , 9306-9316
Sleeping Sickness Disrupts the Sleep-Regulating Adenosine System
Patients with sleeping sickness, caused by the parasiteTrypanosoma brucei, have disruptions in both sleep timing and sleep architecture. However, the underlying cause of these sleep disturbances is not well understood. Here, we assessed the sleep architecture of male mice infected withT. bruceiand found that infected mice had drastically altered sleep patterns. Interestingly,T. brucei-infected mice also had a reduced homeostatic sleep response to sleep deprivation, a response modulated by the adenosine system. We found that infected mice had a reduced electrophysiological response to an adenosine receptor antagonist and increased adenosine receptor gene expression. Although the mechanism by whichT. bruceiinfection causes these changes remains to be determined, our findings suggest that the symptoms of sleeping sickness may be because of alterations in homeostatic adenosine signaling.SIGNIFICANCE STATEMENTSleeping sickness is a fatal disease that disrupts the circadian clock, causes disordered temperature regulation, and induces sleep disturbance. To examine the neurologic effects of infection in the absence of other symptoms, in this study, we used a mouse model of sleeping sickness in which the acute infection was treated but brain infection remained. Using this model, we evaluated the effects of the sleeping sickness parasite,Trypanosoma brucei, on sleep patterns in mice, under both normal and sleep-deprived conditions. Our findings suggest that signaling of adenosine, a neuromodulator involved in mediating homeostatic sleep drive, may be reduced in infected mice.
- 23 October 2020
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 40 (48) , 9306-9316
Open AccessSleeping Sickness Disrupts the Sleep-Regulating Adenosine System
Patients with sleeping sickness, caused by the parasiteTrypanosoma brucei, have disruptions in both sleep timing and sleep architecture. However, the underlying cause of these sleep disturbances is not well understood. Here, we assessed the sleep architecture of male mice infected withT. bruceiand found that infected mice had drastically altered sleep patterns. Interestingly,T. brucei-infected mice also had a reduced homeostatic sleep response to sleep deprivation, a response modulated by the adenosine system. We found that infected mice had a reduced electrophysiological response to an adenosine receptor antagonist and increased adenosine receptor gene expression. Although the mechanism by whichT. bruceiinfection causes these changes remains to be determined, our findings suggest that the symptoms of sleeping sickness may be because of alterations in homeostatic adenosine signaling.SIGNIFICANCE STATEMENTSleeping sickness is a fatal disease that disrupts the circadian clock, causes disordered temperature regulation, and induces sleep disturbance. To examine the neurologic effects of infection in the absence of other symptoms, in this study, we used a mouse model of sleeping sickness in which the acute infection was treated but brain infection remained. Using this model, we evaluated the effects of the sleeping sickness parasite,Trypanosoma brucei, on sleep patterns in mice, under both normal and sleep-deprived conditions. Our findings suggest that signaling of adenosine, a neuromodulator involved in mediating homeostatic sleep drive, may be reduced in infected mice.
- Open Access
- 27 August 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
An essential role for MEF2C in the cortical response to loss of sleep in mice
Neuronal activity and gene expression in response to the loss of sleep can provide a window into the enigma of sleep function. Sleep loss is associated with brain differential gene expression, an increase in pyramidal cell mEPSC frequency and amplitude, and a characteristic rebound and resolution of slow wave sleep-slow wave activity (SWS-SWA). However, the molecular mechanism(s) mediating the sleep-loss response are not well understood. We show that sleep-loss regulates MEF2C phosphorylation, a key mechanism regulating MEF2C transcriptional activity, and that MEF2C function in postnatal excitatory forebrain neurons is required for the biological events in response to sleep loss in C57BL/6J mice. These include altered gene expression, the increase and recovery of synaptic strength, and the rebound and resolution of SWS-SWA, which implicate MEF2C as an essential regulator of sleep function.
- 27 August 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Open AccessAn essential role for MEF2C in the cortical response to loss of sleep in mice
Neuronal activity and gene expression in response to the loss of sleep can provide a window into the enigma of sleep function. Sleep loss is associated with brain differential gene expression, an increase in pyramidal cell mEPSC frequency and amplitude, and a characteristic rebound and resolution of slow wave sleep-slow wave activity (SWS-SWA). However, the molecular mechanism(s) mediating the sleep-loss response are not well understood. We show that sleep-loss regulates MEF2C phosphorylation, a key mechanism regulating MEF2C transcriptional activity, and that MEF2C function in postnatal excitatory forebrain neurons is required for the biological events in response to sleep loss in C57BL/6J mice. These include altered gene expression, the increase and recovery of synaptic strength, and the rebound and resolution of SWS-SWA, which implicate MEF2C as an essential regulator of sleep function.
- Open Access
- 29 April 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (19) , 10547-10553
Loss of Arc attenuates the behavioral and molecular responses for sleep homeostasis in mice
Significance: Arc is a neural immediate early gene involved in synaptic downscaling and is robustly induced by prolonged wakefulness in rodent brains. However, it remains unclear if and how Arc is involved in sleep regulation. Here we find that Arc is important for inducing multiple homeostatic responses induced by sleep deprivation at behavioral and molecular levels: (1) rebound of sleep time; (2) expression of a subset of sleep deprivation-induced genes; and (3) synaptic glutamate receptor expression. In sleep-deprived wild-type brains, Arc protein levels are significantly increased in the nucleus, cytoplasm, and synapse, suggesting multiple roles for Arc depending on its subcellular location. These findings provide the functional evidence for the role of Arc in homeostatic sleep regulation.
- 29 April 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (19) , 10547-10553
Open AccessLoss of Arc attenuates the behavioral and molecular responses for sleep homeostasis in mice
Significance: Arc is a neural immediate early gene involved in synaptic downscaling and is robustly induced by prolonged wakefulness in rodent brains. However, it remains unclear if and how Arc is involved in sleep regulation. Here we find that Arc is important for inducing multiple homeostatic responses induced by sleep deprivation at behavioral and molecular levels: (1) rebound of sleep time; (2) expression of a subset of sleep deprivation-induced genes; and (3) synaptic glutamate receptor expression. In sleep-deprived wild-type brains, Arc protein levels are significantly increased in the nucleus, cytoplasm, and synapse, suggesting multiple roles for Arc depending on its subcellular location. These findings provide the functional evidence for the role of Arc in homeostatic sleep regulation.